ClinicalTrials.gov
public full text
Public Domain
Raltegravir as Early Therapy in African-Americans Living With HIV Study
This is a single arm, longitudinal study to examine the safety, tolerability, and pharmacokinetic and metabolic characteristics of Raltegravir among 40 African-American, HIV-infected, patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients#857364
- Metabolism of Nicotine and Cotinine in Pregnant African-American Women#1008203
- Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)#802659
- Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs#1046211
- Birmingham Access to Care Study#883981
Record · ID 847312
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive